Page last updated: 2024-08-17

colchicine and Metabolic Syndrome

colchicine has been researched along with Metabolic Syndrome in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (11.11)	29.6817
2010's	4 (44.44)	24.3611
2020's	4 (44.44)	2.80

Authors

Authors	Studies
Babyak, A; Biancotto, A; Brady, SM; Chivukula, KK; Dagur, PK; Demidowich, AP; Fantoni, G; Han, JM; Levine, JA; Miller, E; Patel, TP; Periwal, V; Remaley, AT; Sarrafan-Chaharsoughi, Z; Wolska, A; Yanovski, JA	1
Apps, R; Chen, J; Cheung, FK; Demidowich, AP; Fantoni, G; Levine, JA; Patel, TP; Yanovski, JA	1
Koretz, RL	1
Ajala, ON; Everett, BM	1
Brady, SM; Broadney, MM; Chen, KY; Demidowich, AP; Khan, SM; Levine, JA; Onyekaba, GI; Yanovski, JA	1
Bardin, T; Doherty, M; Jansen, TL; Nuki, G; Pascual, E; Perez-Ruiz, F; Punzi, L; Richette, P; So, AK	1
Anastasiadou, K; Eugenidis, N; Gavalas, E; Giouleme, O; Katsinelos, P; Kountouras, J; Nikolaidis, N; Polyzos, SA; Stefanidis, E; Tzathas, C; Zeglinas, C	1
Taniguchi, A	2

Reviews

4 review(s) available for colchicine and Metabolic Syndrome

Article	Year
Targeting Inflammation to Reduce Residual Cardiovascular Risk. Current atherosclerosis reports, 2020, 09-03, Volume: 22, Issue:11 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; C-Reactive Protein; Cardiovascular Diseases; Colchicine; Diabetes Mellitus, Type 2; Heart Disease Risk Factors; Humans; Interleukin-1beta; Metabolic Syndrome; Treatment Outcome; Vasculitis	2020
Improving cardiovascular and renal outcomes in gout: what should we target? Nature reviews. Rheumatology, 2014, Volume: 10, Issue:11 Topics: Allopurinol; Cardiovascular Diseases; Colchicine; Diabetes Mellitus, Type 2; Disease Management; Gout; Gout Suppressants; Humans; Hyperuricemia; Inflammation; Metabolic Syndrome; Probenecid; Renal Insufficiency, Chronic; Treatment Outcome; Uricosuric Agents; Xanthine Oxidase	2014
[Therapy for gout and pseudogout]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2008, Oct-10, Volume: 97, Issue:10 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcium Pyrophosphate; Chondrocalcinosis; Colchicine; Evidence-Based Medicine; Gout; Humans; Hyperuricemia; Joints; Metabolic Syndrome; Prednisolone	2008
[Treatment of hyperuricemia and gout based on the guideline for the management of hyperuricemia and gout]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2010, Volume: 136, Issue:6 Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Benzbromarone; Colchicine; Glucocorticoids; Gout; Gout Suppressants; Humans; Hyperuricemia; Life Style; Metabolic Syndrome; Practice Guidelines as Topic; Probenecid; Uricosuric Agents	2010

Trials

3 trial(s) available for colchicine and Metabolic Syndrome

Article	Year
Effects of colchicine on lipolysis and adipose tissue inflammation in adults with obesity and metabolic syndrome. Obesity (Silver Spring, Md.), 2022, Volume: 30, Issue:2 Topics: Adipose Tissue; Adult; Biomarkers; Colchicine; Humans; Inflammation; Insulin; Insulin Resistance; Lipolysis; Metabolic Syndrome; Obesity	2022
Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial. International journal of obesity (2005), 2020, Volume: 44, Issue:8 Topics: Adult; Anti-Inflammatory Agents; Betacoronavirus; C-Reactive Protein; Colchicine; Coronavirus Infections; COVID-19; Double-Blind Method; Female; Humans; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Obesity; Pandemics; Pilot Projects; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome; Young Adult	2020
Effects of colchicine in adults with metabolic syndrome: A pilot randomized controlled trial. Diabetes, obesity & metabolism, 2019, Volume: 21, Issue:7 Topics: Adult; Anti-Inflammatory Agents; Blood Glucose; C-Reactive Protein; Colchicine; Female; Humans; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Pilot Projects	2019

Other Studies

2 other study(ies) available for colchicine and Metabolic Syndrome

Article	Year
JPEN Journal Club 56. Primary Outcomes. JPEN. Journal of parenteral and enteral nutrition, 2021, Volume: 45, Issue:2 Topics: Adult; Colchicine; Enteral Nutrition; Humans; Metabolic Syndrome; Parenteral Nutrition; Pilot Projects	2021
Colchicine to decrease inflammation and fibrosis in patients with metabolic dysregulation. Medical hypotheses, 2016, Volume: 95 Topics: Animals; Anti-Inflammatory Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Colchicine; Fibrosis; Humans; Inflammation; Metabolic Syndrome; Models, Theoretical; Obesity; T-Lymphocytes, Cytotoxic	2016